🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
RBC Bioscience Corporation (TPEX:6848)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.60
-1.45 (-7.23%)
Nov 20, 2026, 1:48 PM CST

RBC Bioscience Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
21.6736.4479.8665.1875.9397.47
Cash & Short-Term Investments
21.6736.4479.8665.1875.9397.47
Cash Growth
-40.54%-54.37%22.53%-14.16%-22.10%-21.36%
Accounts Receivable
27.826.2113.492325.5924.68
Other Receivables
1.131.021.270.70.711.33
Receivables
28.9327.2314.7623.726.326.01
Inventory
55.1447.4952.7644.4247.251.2
Other Current Assets
8.599.19.436.917.4733.95
Total Current Assets
114.32120.26156.8140.21156.9208.62
Property, Plant & Equipment
503.5508.55520.97533.54556.74621.22
Other Intangible Assets
15.117.1812.873.142.453.17
Long-Term Deferred Tax Assets
3.183.183.533.263.414.09
Other Long-Term Assets
70.1975.3369.7173.6371.0510.51
Total Assets
706.29724.49763.88753.79790.55847.6

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
29.2324.0723.7715.7222.7135.75
Accrued Expenses
4.8213.8613.04---
Short-Term Debt
61-25354064.65
Current Portion of Long-Term Debt
-33.3427.9223.0322.692.11
Current Portion of Leases
1.481.011.131.021.771.98
Current Income Taxes Payable
-5.134.921.268.518.05
Current Unearned Revenue
2.940.710.920.310.261.34
Other Current Liabilities
61.7318.0914.9123.4327.834.2
Total Current Liabilities
161.296.2111.699.77123.74148.07
Long-Term Debt
331.1356.37399.8412.33416.63439.82
Long-Term Leases
1.650.460.850.270.662.43
Long-Term Unearned Revenue
1.190.940.610.430.430.45
Pension & Post-Retirement Benefits
1.691.71.44---
Other Long-Term Liabilities
0.290.290.290.290.29-
Total Liabilities
497.12455.96514.58513.08541.73590.77

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
142.73142.73129.76129.76129.76117.96
Additional Paid-In Capital
-50.4550.4550.4550.4550.45
Retained Earnings
66.4375.3669.0960.568.6188.42
Shareholders' Equity
209.16268.54249.3240.71248.81256.83
Total Liabilities & Equity
706.29724.49763.88753.79790.55847.6

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
395.23391.17454.7471.65481.75510.99
Net Cash (Debt)
-373.57-354.73-374.84-406.47-405.82-413.52
Net Cash Growth
------
Net Cash Per Share
-26.00-24.66-26.11-28.42-28.35-30.57
Filing Date Shares Outstanding
1614.2714.2714.2714.2714.27
Total Common Shares Outstanding
1614.2714.2714.2714.2714.27
Working Capital
-46.8824.0645.240.4533.1660.55
Book Value Per Share
13.0718.8117.4716.8617.4317.99
Tangible Book Value
194.06251.36236.43237.57246.36253.66
Tangible Book Value Per Share
12.1317.6116.5616.6417.2617.77
Land
-354.26354.26354.26354.26401.43
Buildings
-168.6170.11170.11183.13193.16
Machinery
-78.0976.375.9669.1460.79